EVGN Evogene Ltd. - Ordinary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 26, 2026
$0.43
· of 52w range
· above low
· to high
$0.3552w low
$1.5052w high
P/E
1.0
EPS
$1.08
Revenue
$4M
your badges
52W Range
$0–$2
Analyst Rating
BUY
Price Target
$2
P/E
1.0
ROE
1107.0%
Net Profit Margin
-220.2%
Your badge strip is empty — pin a metric anywhere on this page.
EVGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.42
P/E
1.0
EPS
$1.08
Revenue
$4M
ROE
1107.0%
52W Range
$0–$2
EVGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| July 25, 2024 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$4M2016-12-31 → 2025-12-31
EPS$1.082020-12-31 → 2025-12-31
Free Cash Flow$-14M2017-12-31 → 2025-12-31
Net margin-220.2%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | EVGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 1.05Y avg ≈-5.2 | ≈-5.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | EVGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | -6.2%5Y avg ≈39.1% | ≈39.1% | 54.7% | Weak | |
| Operating Margin | -364.2%5Y avg ≈-1206.4% | ≈-1206.4% | -424.3% | In line | |
| EBITDA Margin | -364.2%5Y avg ≈-1206.4% | ≈-1206.4% | -405.0% | In line | |
| Pretax Margin | -350.3%5Y avg ≈-1214.3% | ≈-1214.3% | · | · | |
| Net Profit Margin | -220.2%5Y avg ≈-1083.2% | ≈-1083.2% | -352.4% | Top tier | |
| ROA | -28.3%5Y avg ≈-37.4% | ≈-37.4% | -75.0% | Top tier | |
| ROE | 1107.0%5Y avg ≈111.1% | ≈111.1% | 126.2% | Top tier | |
| ROIC | 17115.9%5Y avg ≈3654.6% | ≈3654.6% | 53.8% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | EVGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 4.55Y avg ≈5.1 | ≈5.1 | 2.1 | Strong liquidity | |
| Quick Ratio | 3.65Y avg ≈2.4 | ≈2.4 | 1.1 | Strong liquidity | |
| Interest Coverage | -7.35Y avg ≈-14.3 | ≈-14.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | EVGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.1 | ≈0.1 | 0.1 | Weak | |
| Inventory Turnover | 4.05Y avg ≈6.3 | ≈6.3 | · | · | |
| Revenue / Employee | ≈$101.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
4.7%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.14 | $-0.28 | 49.2% |
| March 31, 2026 | May 20, 2026 | $-0.60 | $-0.28 | -117.9% |
| Dec. 31, 2025 | $-0.61 | $-0.27 | -130.0% | |
| Sept. 30, 2025 | $0.44 | $-0.42 | 205.2% | |
| June 30, 2025 | $-0.62 | $-0.64 | 3.5% | |
| March 31, 2025 | $-0.38 | $-0.46 | 18.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $6M | $3M | $2M | $930.0K | $1M | $753.0K | $2M | $3M | $7M | |
| Cost of Revenue | $4M | $2M | $1M | $909.0K | $767.0K | $574.0K | $334.0K | $1M | $3M | $6M | |
| Gross Profit | $-241.0K | $3M | $1M | $766.0K | $163.0K | $466.0K | $419.0K | $295.0K | $536.0K | $901.0K | |
| R&D Expense | $8M | $13M | $16M | $21M | $21M | $17M | $16M | $15M | $17M | $16M | |
| SG&A Expense | $4M | $7M | $5M | $6M | $7M | $5M | $4M | $4M | $4M | $4M | |
| Operating Income | $-14M | $-19M | $-22M | $-27M | $-31M | $-25M | $-21M | $-20M | $-22M | $-21M | |
| Interest Expense | $2M | $3M | $928.0K | $3M | $1M | $3M | $555.0K | $2M | $1M | $891.0K | |
| Interest Income | $3M | $7M | $1M | $516.0K | $2M | $2M | $3M | $1M | $2M | $2M | |
| Pretax Income | $-13M | $-15M | $-22M | $-30M | $-30M | $-26M | $-19M | $-21M | $-21M | $-20M | |
| Income Tax | $1.0K | $9.0K | $19.0K | $90.0K | $13.0K | $32.0K | $24.0K | $30.0K | $11.0K | $36.0K | |
| Net Income | $-8M | $-16M | $-24M | $-27M | $-28M | $-23M | $-18M | $-21M | $-21M | $-20M | |
| EPS (Basic) | $1.08 | $-2.90 | $-5.20 | $-6.44 | $-0.69 | $-0.83 | · | · | · | · | |
| EPS (Diluted) | $1.08 | $-2.90 | $-5.20 | $-6.44 | $-0.69 | $-0.83 | · | · | · | · | |
| Shares (Basic) | 7,874,039 | 5,697,245 | 4,589,386 | 4,141,842 | 40,433,303 | 28,158,779 | 25,754,297 | 25,753,411 | 25,673,276 | 25,444,733 | |
| Shares (Diluted) | 7,874,039 | 5,697,245 | 4,589,386 | 4,141,842 | 40,433,303 | 28,158,779 | · | · | · | · | |
| EBITDA | $-14M | $-22M | $-27M | $-27M | $-31M | $-25M | $-21M | $-20M | $-22M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $14M | $19M | $22M | $8M | $33M | $25M | $2M | $3M | $2M | |
| Inventory | $210.0K | $2M | $76.0K | $566.0K | $92.0K | $0 | · | · | · | · | |
| Current Assets | $16M | $22M | $34M | $38M | $57M | $52M | $49M | $55M | $73M | $89M | |
| PP&E (Net) | $812.0K | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $5M | $6M | |
| Intangibles | $0 | $12M | $13M | $14M | $15M | $16M | $17M | · | · | · | |
| Total Assets | $20M | $40M | $51M | $56M | $76M | $72M | $71M | $59M | $78M | $96M | |
| Accounts Payable | $639.0K | $1M | $2M | $1M | $1M | $863.0K | $1M | $1M | $1M | $1M | |
| Current Liabilities | $3M | $19M | $7M | $6M | $7M | $10M | $6M | $5M | $5M | $5M | |
| Total Liabilities | $8M | $25M | $22M | · | · | · | · | · | · | · | |
| Retained Earnings | $-283M | $-274M | $-258M | $-234M | $-207M | $-179M | $-156M | $-138M | $-117M | $-96M | |
| Stockholders' Equity | $-82.0K | $-1M | $12M | $28M | $54M | $46M | $50M | $50M | $69M | $87M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-14M | $-20M | $-22M | $-24M | $-25M | $-20M | $-18M | $-15M | $-16M | $-12M | |
| CapEx | $135.0K | $626.0K | $577.0K | $1M | $847.0K | $682.0K | $900.0K | $374.0K | $590.0K | $808.0K | |
| Investing Cash Flow | $18M | $10M | $-5M | $13M | $-21M | $9M | $37M | $17M | $15M | $4M | |
| Financing Cash Flow | $-7M | $5M | $18M | $9M | $30M | $20M | $9M | $297.0K | $814.0K | $655.0K | |
| Free Cash Flow | $-14M | $-20M | $-22M | $-25M | $-26M | $-20M | $-19M | $-16M | $-17M | · | |
| Levered FCF | $-16M | $-24M | $-23M | $-28M | $-27M | $-23M | $-19M | $-18M | $-18M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -6.2% | 68.5% | 70.0% | 45.7% | 17.5% | 44.8% | 55.6% | 16.9% | 15.8% | · | |
| Operating Margin | -364.2% | -261.0% | -470.0% | -1608.4% | -3328.3% | -2386.0% | -2810.9% | -1144.2% | -649.1% | · | |
| Net Margin | -220.2% | -193.7% | -423.4% | -1590.3% | -2988.5% | -2247.5% | -2405.3% | -1188.2% | -616.3% | · | |
| Pretax Margin | -350.3% | -212.0% | -460.8% | -1776.4% | -3272.3% | -2516.7% | -2535.3% | -1189.6% | -616.0% | · | |
| EBITDA Margin | -364.2% | -261.0% | -470.0% | -1608.4% | -3328.3% | -2386.0% | -2810.9% | -1144.2% | -649.1% | · | |
| ROA | -28.3% | -36.2% | -44.5% | -40.2% | -37.5% | -32.6% | -27.9% | -30.5% | -24.0% | · | |
| ROE | 1107.0% | -311.0% | -119.4% | -65.3% | -55.8% | -48.6% | -36.1% | -34.8% | -26.6% | · | |
| ROIC | 17115.9% | 1531.4% | -219.6% | -96.8% | -57.7% | -54.0% | -42.3% | -40.0% | -31.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 1.2 | 5.0 | 6.7 | 8.3 | 5.4 | 8.6 | 10.2 | 15.6 | · | |
| Quick Ratio | 3.6 | 0.7 | 2.7 | 4.0 | 1.1 | 3.4 | 4.3 | 0.4 | 0.6 | · | |
| Interest Coverage | -7.3 | -6.6 | -27.5 | -8.1 | -21.9 | -8.4 | -38.1 | -9.1 | -21.8 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 4.0 | 2.8 | 5.3 | 2.8 | 16.7 | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.49 | $1.49 | $0.12 | $0.04 | · | · | · | · | · | · | |
| Cash Flow / Share | $-1.71 | $-3.46 | $-0.47 | $-0.57 | · | · | · | · | · | · | |
| EPS (TTM) | $1.08 | $-2.90 | $-5.20 | $-6.44 | $-0.69 | $-0.83 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $6M | $3M | $2M | $930.0K | $1M | $753.0K | $2M | $3M | · | |
| Net Income TTM | $-8M | $-16M | $-24M | $-27M | $-28M | $-23M | $-18M | $-21M | $-21M | · | |
| P/E | 1.0 | -0.6 | -1.6 | -1.1 | -23.8 | -56.6 | · | · | · | · | |
| Earnings Yield | 98.2% | -155.1% | -61.9% | -92.0% | -4.2% | -1.8% | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|---|
| Revenue TTM | $7M | $11M | · | · | |
| Net Income TTM | $-20M | $-17M | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $4M | $6M | $3M | $2M | $930.0K |
| Gross Margin % | -6.2% | 68.5% | 70.0% | 45.7% | 17.5% |
| Operating Margin % | -364.2% | -261.0% | -470.0% | -1608.4% | -3328.3% |
| Net Income | $-8M | $-16M | $-24M | $-27M | $-28M |
| Diluted EPS | $1.08 | $-2.90 | $-5.20 | $-6.44 | $-0.69 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 4.5 | 1.2 | 5.0 | 6.7 | 8.3 |
| Quick Ratio | 3.6 | 0.7 | 2.7 | 4.0 | 1.1 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-14M | $-20M | $-22M | $-25M | $-26M |
Institutional owners (13F) 13 filers · $75K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
13
Value held
$75K
New positions
3
Exited positions
5
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 3 (0 vs prior Q) | 5 (0 vs prior Q) | 2 (+1 vs prior Q) | 4 (-1 vs prior Q) | -248K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $33,889 | 80,078 | 45.16% | Shares |
| CITADEL ADVISORS LLC | $21,383 | 50,526 | 28.49% | Shares |
| XTX Topco Ltd | $8,212 | 19,404 | 10.94% | Shares |
| UBS Group AG | $4,737 | 10,790 | 6.31% | Shares |
| Daytona Street Capital LLC | $4,651 | 9,253 | 6.20% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,242 | 2,830 | 1.66% | Shares |
| MORGAN STANLEY | $564 | 1,285 | 0.75% | Shares |
| Federation des caisses Desjardins du Quebec | $220 | 500 | 0.29% | Shares |
| HRT FINANCIAL LP | $45 | 107,198 | 0.06% | Shares |
| OSAIC HOLDINGS, INC. | $44 | 100 | 0.06% | Shares |
| SHP Wealth Management | $29 | 65 | 0.04% | Shares |
| SBI Securities Co., Ltd. | $27 | 62 | 0.04% | Shares |
| ROYAL BANK OF CANADA | $0 | 42 | 0.00% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RECANATI LEON ×3 filings | Sept. 11, 2026 | 8.60% | Amendment | · | SEC |
| Invest Pro Shukai Hon Ltd., Kfir Silberman, L.I.A. Pure Capital Ltd., Ron Yair Peled ×2 filings | Sept. 11, 2026 | 19.35% | Amendment | · | SEC |
| L.I.A. Pure Capital Ltd., Kfir Silberman, Invest Pro Shukai Hon Ltd., Ron Yair Peled ×5 filings | Aug. 13, 2026 | 19.35% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 5 insiders · 1 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Gabi Tarcic | Chief Development Officer | June 4, 2026 P | 1,129 | 1 | 0 | $677 |
| Adrian John Percy | Director | Sept. 4, 2026 A | · | 0 | 0 | $0 |
| Dan Michael Falk | Director | Sept. 4, 2026 A | · | 0 | 0 | $0 |
| Nir Nimrodi | Director | Sept. 4, 2026 A | · | 0 | 0 | $0 |
| RECANATI LEON | Director | Sept. 4, 2026 A | 1,343,886 | 2 | 0 | $694,400 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
EVGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$2.15
+405.9%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-20Mean target $2.15 +405.9%
Low$2.15
Mean$2.15
High$2.15
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| EVGN | · | 1.0 | · | -220.2% | 1107.0% | -6.2% |
| QNRX | $757M | · | · | · | -201.7% | · |
| CMMB | · | 91.7 | · | · | -69.5% | · |
| NRSN | $25M | -1.7 | · | · | -2175.0% | · |
| ENLV | $167M | 0.0 | · | · | 126.2% | · |
| CLGN | $18M | -1.5 | · | -484.6% | -117.6% | 64.8% |
| SLXN | · | 0.2 | · | · | · | · |
| SCNI | $9.88B | · | · | -633.6% | -91.9% | -202.3% |
| URGN | $1.13B | · | 21.4% | -139.8% | 154.4% | 88.7% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 26, 2026